First patient in Canada receives mRNA-based bladder cancer treatment in clinical trial at the MUHC 

The investigational therapy combines mRNA technology with immunotherapy to train the immune system to target cancer cells after surgery In a new milestone in precision cancer medicine for the Research Institute of the McGill University Health Centre (The Institute) and McGill University's Faculty of Medicine and Health Sciences, a patient…